Endocrinology Flashcards
T1DM risk factors
HLA DR3-DQ2 or HLA DR4-DQ8
Autoimmune diseases
T1DM pathophysiology
Autoantibodies attack Beta cells in the Islets of Langerhans -> Insulin deficiency -> hyperglycaemia
Continuous breakdown of glycogen from liver (gluconeogenesis) -> glycosuria
T1DM diagnosis
Random plasma glucose > 11mmol/L
T1DM management
Education
Insulin
Short-acting insulins and insulin analogues - 4-6 hours
Longer acting insulin - 12-24 hours
T2DM risk factors
Lifestyle factors: obesity, lack of exercise, calorie and alcohol excess
Higher prevalence in asian men
> 40 years old - later onset
Hypertension
T2DM investigation results
Fasting plasma glucose > 7 mmol/L
Random plasma glucose > 11 mmol/L
OGTT after 2 hours > 11 mmol/L
HbA1c > 48 mmol/L
Impaired glucose tolerance investigation results
Fasting plasma glucose > 6 mmol/L
OGTT after 2 hours > 7.8 mmol/L
T2DM lifestyle changes as 1st line management
Dietary advice: high in complex carbs, low in fat
Smoking cessation
Decrease alcohol intake
Encourage exercise
Regular blood glucose and HbA1c monitoring
T2DM pharmacological management
1st: Metformin
[+ SGLT-2 inhibitors if heart failure!]
2nd:
Dual therapy: + SGLT-2 inhibitor, sulphonylurea, pioglitazone, DPP4 inhibitors
3rd:
Triple therapy
4th:
Insulin
Injectables are last line
DKA pathophysiology
Absence of insulin -> uncontrolled catabolism -> unrestrained gluconeogenesis and decreased peripheral glucose uptake -> hyperglycaemia
Hyperglycemia -> osmotic diuresis -> dehydration
Peripheral lipolysis for energy -> increase in circulating free fatty acids -> oxidised to Acetyl CoA -> ketone bodies (acidic) = Acidosis
DKA general management
IV fluids - 0.9% saline
IV insulin
K+ replacement
Hyperosmolar hyperglycaemic state pathophysiology
Low insulin -> increased gluconeogenesis -> hyperglycaemia, but enough insulin to inhibit ketogenesis
Hyperglycemia -> osmotic diuresis -> dehydration
Hyperosmolar hyperglycaemic state investigation results
Random plasma glucose >11mmol/L
Urine dipstick: glucosuria
Plasma osmolality - high
U+E - ↓ total body K+, ↑ serum K+
Hyperosmolar hyperglycaemic state treatment
Replace fluid - 0.9% saline IV
Insulin - At low rate of infusion!
Restore electrolytes - e.g. K+
LMWH
Hyperosmolar hyperglycaemic state manifestations
Extreme diabetes symptoms
Plus:
Confusion and reduced mental state
Lethargy
Severe dehydration
Hyperthyroidism risk factors
Smoking
Stress
HLA-DR3
Other autoimmune diseases: T1DM, Addisons, Vitiligo
Causes of hyperthyroidism
Graves disease - 65-75%, Autoimmune, F>M - 9:1
Toxic multinodular goitre
Toxic adenoma
Metastatic follicular thyroid cancer
Iodine excess (e.g. IV contrast)
Secondary causes - TSH secreting pituitary tumour
Hyperthyroidism pathophysiology
↑T3 increases metabolic rate, cardiac output, bone resorption and activates sympathetic nervous system
Grave’s disease pathophysiology
IgG autoantibodies (anti-TSHR-Ab) bind to TSH receptors to increase T4/T3 production
They also react with orbital autoantigens
Hyperthyroidism presentation
Hot + sweaty
Diarrhoea
Hyperphagia
Weight loss
Palpitations
Tremor
Irritability
Anxiety/restlessness
Oligomenorrhoea
Goitre
Grave’s disease: eye symptoms + other
Thyroid eye disease (25-50%)
Eyelid retraction
Periorbital swelling
Proptosis/Exophthalmos
Pretibial myxoedema
Thyroid acropachy
Hyperthyroidism TFTs + antibodies + other investigations
TFTs - ↑T4/T3, Primary: ↓TSH, Secondary: ↑TSH
Thyroid autoantibodies (anti-TSHR)
US + CT Head
Hyperthyroidism management
Drug management
Beta-blockers - Rapid symptom relief
1st line Carbimazole - Blocks synthesis of T4
2nd line Propylthiouracil - Prevents T4->T3 conversion
Radioiodine
Thyroidectomy
Most common cause of hypothyroidism worldwide
Iodine deficiency
Most common cause of hypothyroidism in UK
Hashimoto’s thyroiditis
Most common cause of hypothyroidism in consanguin relationships
Congenital hypothyroidism
Wolff-Chaikoff effect
Iodine excess causing hypothyroidism
Inhibits thyroid hormone synthesis
Causes of hypothyroidism
Autoimmune causes
Hashimotos (inflammation -> goitre). More common F 60-70 years old
Primary atrophic hypothyroidism (atrophy -> no goitre)
Other primary
Iodine deficiency
Drugs (antithyroid drugs, iodine, lithium)
Post thyroidectomy/ radioiodine
Secondary - Hypopituitarism
Hypothyroidism manifestations
Fatigue
Weight gain
Loss of appetite
Cold
Lethargy
Constipation
Low mood/depression
Menorrhagia
Goitre
Hypothyroidism investigations + results
TFTs
↓T4 ↓T3
Primary: ↑TSH
Secondary ↓TSH
Autoantibodies (anti-TPO)
Cushing’s syndrome causes
ACTH dependent:
Cushing’s Disease-ACTH secreting from pituitary adenoma
Ectopic ACTH production from small cell lung cancer
ACTH independent:
Iatrogenic- Steroid use(most common)
Adrenal adenoma
Cushing’s syndrome features
Moon face
Central obesity
Buffalo hump
Acne
Hypertension
Striae
Hirsutism
Weight gain
Cushing’s syndrome investigations + results
Random plasma cortisol- raised
Overnight dexamethasone suppression test- cortisol will not be suppressed in Cushing’s Disease
Urinary free cortisol (24 hr)
Plasma ACTH
Cushing’s syndrome treatment
Iatrogenic: stop medications if possible
Cushing’s disease: removal of pituitary adenoma= transsphenoidal surgery
Adrenal adenoma: adrenalectomy
Cortisol synthesis inhibition:
Metyrapone, Ketoconazole
Acromegaly causes
Pituitary Adenoma= most common(99%)
Secondary to a malignancy that secretes ectopic GH eg. lung cancer
Acromegaly pathophysiology
GH acts directly on tissues such as liver, muscle bone or fat, as well as indirectly through induction of insulin like growth factor